genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Kite Pharma
Drug Discovery
$600M+ Credit Firm Targets Life-Sci Companies in Later Stages
Bioprocessing
Cytiva Launches Next-Gen Cell Therapy Manufacturing Platform
A-Lists
Top 10 U.S. Biopharma Clusters
Cancer
Targeted Therapies to Reduce Side Effects in Modern Drug Development
Cancer
Draper Aims High as a Kite against Cancer
Drug Discovery
CAR T-Cell Therapy for Lymphoma Leads to Complete Remission in Phase I Trial
Industry News
Kite Pharma Reports Positive Phase II Interim Data for CAR-T Cell Candidate
Cancer
Kite Pharma, bluebird bio Partner on Cancer Immunotherapies
Cancer
Kite Pharma Acquires T-Cell Factory for $21M Up Front
Scroll Up
Scroll Up
